Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
dalfampridine
placebo
Locations
1
United States
Buffalo General Hospital
Buffalo, New York, United States
Start Date
December 1, 2011
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
October 1, 2020
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
State University of New York at Buffalo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions